Emerald Advisers’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $24.9M | Sell |
|
|||||
|
2022
Q1 | $37.5M | Buy |
|
|||||
|
2021
Q4 | $35.4M | Buy |
|
|||||
|
2021
Q3 | $28.8M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $7M | Sell |
|
|||||
|
2020
Q3 | $12.9M | Sell |
|
|||||
|
2020
Q2 | $36.2M | Sell |
|
|||||
|
2020
Q1 | $19.8M | Buy |
|
|||||
|
2019
Q4 | $26.2M | Buy |
|
|||||
|
2019
Q3 | $13.2M | Sell |
|
|||||
|
2019
Q2 | $14.8M | Sell |
|
|||||
|
2019
Q1 | $30.5M | Buy |
|
|||||
|
2018
Q4 | $21.1M | Sell |
|
|||||
|
2018
Q3 | $21.8M | Buy |
|
|||||
|
2018
Q2 | $16M | Buy |
|
|||||
|
2018
Q1 | $9.36M | Sell |
|
|||||
|
2017
Q4 | $9.98M | Buy |
|
|||||
|
2017
Q3 | $9.1M | Sell |
|
|||||
|
2017
Q2 | $12.4M | Buy |
|